Nuclear Medicine/Radioph armaceutic Market
Nuclear Medicine/Radiopharmaceutic Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Nuclear Medicine/Radiopharmaceutic Market Size and Growth
The Nuclear Medicine/Radiopharmaceutical market is experiencing robust growth, driven by increasing demand for diagnostic imaging and targeted therapies. The market size is projected to reach approximately $12 billion by 2027, reflecting a compound annual growth rate (CAGR) of around 8%.
Advancements in technology and rising healthcare investments are key growth factors. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ GE Healthcare
◍ Bracco Imaging
◍ Mallinckrodt
◍ Lantheus Medical Imaging
◍ Bayer
◍ Jubilant Pharma
◍ Nordion
◍ Eli Lilly
◍ SIEMENS
◍ China Isotope & Radiation
◍ Yantai Dongcheng Biochemicals
The Nuclear Medicine/Radiopharmaceutical Market features key players like GE Healthcare, Bracco Imaging, and Lantheus, enhancing diagnostics and treatment through innovative radiopharmaceuticals. They drive market growth via advanced technologies, strategic partnerships, and expanding product portfolios. Sales revenues include:
- GE Healthcare: ~$19 billion
- Mallinckrodt: ~$2.5 billion
- Lantheus: ~$740 million. Request Sample Report
Market Segmentation
By Application
Diagnostic
Therapeutic
Request Sample Report
By Product
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Market Growth
Request Sample Report
$ X Billion USD
